Intellectual Property India Publishes Patent Application for Glp-1 Receptor Agonist Semaglutide'S Potential For Treating Obesity, Non-Alcoholic Steatohepatitis, And Neurodegenerative Conditions

MUMBAI, India, Oct. 12 -- Intellectual Property India has published a patent application (202611103412 A) filed by Sunil Kumar Tiwari; Bhavesh Yadav; Dr. Vijeta Rajoriya; Yogita Sahu; Dr. Charu Sinha; Chanchla Devi Haldkar; Dr. U. Mohan Kumar; P. Sravanthi; Dr. Mukund Chandra Thakur; Ms. Ayushi Jain; Ms. Nazneen Ansari; and Dr. Shubhasis Dan on August 27, 2026, for Glp-1 Receptor Agonist Semaglutide'S Potential For Treating Obesity, Non-Alcoholic Steatohepatitis, And Neurodegenerative Conditions.

Inventors include Sunil Kumar Tiwari; Bhavesh Yadav; Dr. Vijeta Rajoriya; Yogita Sahu; Dr. Charu Sinha; Chanchla Devi Haldkar; Dr. U. Mohan Kumar; P. Sravanthi; Dr. Mukund Chandra Thakur; Ms. Ayushi Jain; Ms. Nazneen Ansari; and Dr. Shubhasis Dan....